Miaoli, Taiwan

Jinq-Chyi Lee

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: National Health Research Institutes, National Yang Ming Chiao Tung University. Active years: 2014-2023.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jinq-Chyi Lee: Innovator in Pharmaceutical Compounds

Introduction

Jinq-Chyi Lee is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health issues. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Lee's latest patents include innovative compounds such as CDGSH iron sulfur domain 2 activators and Isoindoline compounds, along with their pharmaceutical compositions. These patents also provide methods for treating Cisd2-insufficiency associated disorders and offer protection against doxorubicin-induced cardiotoxicity. Additionally, he has developed glycoside compounds, which are defined by specific formulas, and has disclosed related pharmaceutical compositions and therapeutic methods.

Career Highlights

Throughout his career, Jinq-Chyi Lee has worked with esteemed institutions such as the National Health Research Institutes and National Yang Ming Chiao Tung University. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Lee has collaborated with notable colleagues, including Yu-Sheng Chao and Ting-Fen Tsai. These partnerships have likely enriched his research and led to further innovations in his field.

Conclusion

Jinq-Chyi Lee's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through research and development. His patents reflect a dedication to addressing critical medical challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…